《诺华公司Novartis（NVS）2025年第二季度财务业绩投资者展示报告「NYSE」（英文版）（79页）.pdf》由会员分享，可在线阅读，更多相关《诺华公司Novartis（NVS）2025年第二季度财务业绩投资者展示报告「NYSE」（英文版）（79页）.pdf（79页珍藏版）》请在三个皮匠报告上搜索。

1、 1Novartis Q2 Results|July 17,2025ContentCompany overviewFinancial reviewConclusionsClick below to navigate through the documentAppendixReferencesInvestor presentationJuly 17,2025Q2 2025 Results 2Novartis Q2 Results|July 17,2025ContentCompany overviewFinancial reviewConclusionsClick below to navigat

2、e through the documentAppendixReferencesDisclaimerThis presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995,that can generally be identified by words such as“potential,”“expected,”“will,”“planned,”“pipeline,”“outloo

3、k,”“confident,or similar expressions,or by express or implied discussions regarding potential new products,potential new indications for existing products,potential product launches,or regarding potential future revenues from any such products;or regarding results of ongoing clinical trials;or regar

4、ding potential future,pending or announced transactions;regarding potential future sales or earnings;or by discussions of strategy,plans,expectations or intentions,including discussions regarding our continued investment into new R&D capabilities and manufacturing;or regarding our capital structure.

5、Such forward-looking statements are based on the current beliefs and expectations of management regarding future events and are subject to significant known and unknown risks and uncertainties.Should one or more of these risks or uncertainties materialize,or should underlying assumptions prove incor

6、rect,actual results may vary materially from those set forth in the forward-looking statements.You should not place undue reliance on these statements.There can be no guarantee that the investigational or approved products described in this presentation will be submitted or approved for sale or for